Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Synaptogenix (SNPX) is now available.
Synaptogenix, Inc. has extended the term of Dr. Alan J. Tuchman, their CEO, through an amendment to his offer letter, now ensuring his leadership until at least December 7, 2024, with the possibility of monthly renewals. This move solidifies Dr. Tuchman’s role at the helm of the company, indicating a sustained direction for investors and stakeholders to anticipate in the company’s strategic journey ahead.
Learn more about SNPX stock on TipRanks’ Stock Analysis page.